The Supreme Court on Monday issued notice to the central government on a petition seeking to quash licencing of two vaccines for cervical cancer treatment.
A bench of justices KS Radhakrishnan and Dipak Misra agreed to hear the plea after it was alleged that the Drugs Controller issued licences for the vaccines without adequate research on safety as directed by Parliamentary Standing Committee on Health and Family Welfare in 2010.
APIL has sought quashing of licenses on the ground that the approval for their use was done without adequate research on safety.
'The two companies have also flouted Indian law with impunity and have not done the post marketing studies ordered by the Drugs Controller at the time of licencing. They have not up dated their product information and hence the Indian medical consumer continues to be in the dark about hazards of these vaccines that contain insect cells. MSD Pharmaceuticals went a step further and got the eligible age group extended to 45 year old women in India though this was denied in the US thrice,' the petitioner said.
A bench of justices KS Radhakrishnan and Dipak Misra agreed to hear the plea after it was alleged that the Drugs Controller issued licences for the vaccines without adequate research on safety as directed by Parliamentary Standing Committee on Health and Family Welfare in 2010.
APIL has sought quashing of licenses on the ground that the approval for their use was done without adequate research on safety.
'The two companies have also flouted Indian law with impunity and have not done the post marketing studies ordered by the Drugs Controller at the time of licencing. They have not up dated their product information and hence the Indian medical consumer continues to be in the dark about hazards of these vaccines that contain insect cells. MSD Pharmaceuticals went a step further and got the eligible age group extended to 45 year old women in India though this was denied in the US thrice,' the petitioner said.